Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-12-14 | Joanne Waldstreicher, M.D. | 63 Former Chief Medical Officer, Johnson & Johnson Director Since: 2023 Independent: Yes Committees: Corporate Governance and Nominating, Quality and Regulatory Fiscal 2023 director compensation: Total 119,916 |
| 2024-12-19 | Dr. Waldstreicher brings to the Board over 30 years of experience in clinical and strategic leadership roles. |
Data sourced from SEC filings. Last updated: 2025-07-01